Background: COVID-19 symptoms vary widely among pregnant women. We aimed to assess the most frequent symptoms amongst pregnant women with SARS-CoV-2 infection in a tertiary hospital in Mexico City.

Methods: A cross-sectional study of pregnant women attending the National Institute of Perinatology in Mexico City was performed. All women who attended the hospital, despite their symptoms, were tested for SARS-CoV-2. A multivariate-age-adjusted logistic regression was used to assess the association between the main outcome and each characteristic of the clinical history.

Results: A total of 1880 women were included in the data analysis. Among all women, 30.74% ( = 578) had a positive PCR for SARS-CoV-2 from which 2.7 ( = 50) were symptomatic. Symptoms associated with a positive PCR result were headache (=.01), dyspnea (=.043), and myalgia (=.043).

Conclusions: At universal screening for SARS-CoV-2, one-third of the population had a positive result, while those symptoms associated with a positive PCR were headache, dyspnea, and myalgia.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14767058.2021.1902500DOI Listing

Publication Analysis

Top Keywords

pregnant women
16
positive pcr
12
sars-cov-2 infection
8
women attending
8
mexico city
8
symptoms associated
8
associated positive
8
women
7
sars-cov-2
5
symptoms
5

Similar Publications

Cardiovascular disease is a leading cause of morbidity and mortality for pregnant patients. A significant portion of cardiac morbidity and mortality is preventable and related to poor or delayed recognition of clinical warning signs and oversights in management. The establishment of pregnancy heart teams facilitates multidisciplinary planning to improve management of people with cardiovascular disease.

View Article and Find Full Text PDF

Elevated serum uric acid (SUA) levels in pregnancy are linked to adverse outcomes, including preterm birth, preeclampsia, and low birth weight. To assess the predictive value of SUA levels in early pregnancy for adverse pregnancy outcomes (APOs). A cohort of 4,240 pregnant women admitted for delivery from January 2021 to December 2022 was analyzed.

View Article and Find Full Text PDF

The effect of web-based breastfeeding education given to primiparous pregnant women: a randomised controlled study.

Afr J Reprod Health

December 2024

Department of Nursing Obstetrics and Gynaecology Nursing Department, Istanbul-Turkey.

This was a randomised controlled study to investigate the effect of web-based breastfeeding education given to primiparous pregnant women on postpartum breastfeeding. The study included a total of 120 primiparous pregnant women, including control group (n:60) and experimental group (n:60). The study was conducted in a district in northern Turkey.

View Article and Find Full Text PDF

Background: Lamotrigine clearance can change drastically in pregnant women with epilepsy (PWWE) making it difficult to assess the need for dosing adjustments. Our objective was to characterize lamotrigine pharmacokinetics in PWWE during pregnancy and postpartum along with a control group of nonpregnant women with epilepsy (NPWWE).

Methods: The Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) study was a prospective, observational, 20 site, cohort study conducted in the United States (December 2012 and February 2016).

View Article and Find Full Text PDF

Purpose: Acute fatty liver of pregnancy (AFLP) is a severe complication that can occur in the third trimester or immediately postpartum, characterized by rapid hepatic failure. This study aims to explore the changes in portal vein blood flow velocity and liver function during pregnancy, which may assist in the early diagnosis and management of AFLP.

Methods: This longitudinal study was conducted at a tertiary healthcare center with participants recruited from routine antenatal check-ups.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!